Browse > Article

Increased Regulatory T cells in Thyroid Adenocarcinoma in a Mixed Breed Dog  

Kim, Jun-Hwan (Western Animal Medical Center)
Hong, Yeon-Jung (Western Animal Medical Center)
Kim, Bumseok (College of Veterinary Medicine, Chonbuk National University)
Kim, Yunhye (College of Veterinary Medicine, Chonbuk National University)
Park, Jin-Ho (College of Veterinary Medicine, Chonbuk National University)
Chung, Tae-Ho (College of Tourism & Health, Joongbu University)
Park, Chul (College of Veterinary Medicine, Chonbuk National University)
Publication Information
Journal of Veterinary Clinics / v.30, no.6, 2013 , pp. 482-485 More about this Journal
Abstract
This case report describes the increment of regulatory T cells in thyroid carcinoma of a mixed breed dog compared with normal dogs. A mixed breed dog was referred for a submandibular mass and hyperthermia. Right cervical mass was detected during the physical examination and radiography identified right cervical mass suspected thyroid gland. Accurate location and size of mass was confirmed using computed tomography and 3D reconstructed images. After confirmation of mass, surgical resection was performed and evaluation of regulatory T cells in blood of this patient was performed using flow cytometric assay. The percentage of regulatory T cells was 38.28% of all CD4 (+)/CD25 (+) T cells. This result was higher than median percentage of regulatory T cells of healthy 8 beagles ($7.66{\pm}1.65%$ (p<0.01) of all CD4 (+)/CD25 (+) T cells). And masses were confirmed as giant cell thyroid carcinoma based on histopathologic examination. After surgical resection of cervical mass was performed, the owner didn't want chemotherapy. Seven days later, cervical mass came out again. And CBC showed severe leukocytosis (WBC $47.6{\times}10^3/{\mu}L$) and non-regenerative anemia (PCV 21%). Suspected pulmonic metastasis regions became more severe. Finally the dog died of severe anemia and respiratory disorder.
Keywords
dog; regulatory T cell; thyroid carcinoma;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Shevach EM, DiPaolo RA, Andersson J, Zhao DM, Stephens GL, Thornton AM. The lifestyle of naturally occurring cd4+ cd25+ foxp3+ regulatory t cells. Immunol Rev 2006; 212: 60-73.   DOI   ScienceOn
2 Tominaga M, Horiuchi Y, Ichikawa M, Yamashita M, Okano K, Jikumaru Y, Nariai Y, Kadosawa T. Flow cytometric analysis of peripheral blood and tumor-infiltrating regulatory T cells in dogs with oral malignant melanoma. J Vet Diagn Invest 2010; 22: 438-441.   DOI   ScienceOn
3 Wingate PJ, McAulay KA, Anthony IC, Crawford DH. Regulatory t cell activity in primary and persistent epsteinbarr virus infection. J Med Virol 2009; 81: 870-877.   DOI   ScienceOn
4 Yagi H, Nomura T, Nakamura K, Yamazaki S, Kitawaki T, Hori S, Maeda M, Onodera M, Uchiyama T, Fujii S, Sakaguchi S. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 2004; 16: 1643-1656.   DOI   ScienceOn
5 Campbell DJ, Ziegler SF. Foxp3 modifies the phenotypic and functional properties of regulatory t cells. Nat Rev Immunol 2007; 7: 305-310.   DOI   ScienceOn
6 Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W. Specific recruitment of regulatory t cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 942-949.   DOI   ScienceOn
7 Horiuchi Y, Tominaga M, Ichikawa M, Yamashita M, Jikumaru Y, Nariai Y, Nakajima Y, Kuwabara M, Yukawa M. Increase of regulatory t cells in the peripheral blood of dogs with metastatic tumors. Microbiol Immunol 2009; 53: 468-474.   DOI   ScienceOn
8 Kessel A, Bamberger E, Masalha M, Toubi E. The role of T regulatory cells in human sepsis. J Autoimmun 2009; 32: 211-215.   DOI   ScienceOn
9 Mills KH. Regulatory t cells: Friend or foe in immunity to infection? Nat Rev Immunol 2004; 4: 841-855.   DOI   ScienceOn
10 Maloy KJ, Powrie F. Regulatory t cells in the control of immune pathology. Nat Immunol 2001; 2: 816-822.   DOI   ScienceOn
11 O'Neill K, Guth A, Biller B, Elmslie R, Dow S. Changes in regulatory t cells in dogs with cancer and associations with tumor type. J Vet Intern Med 2009; 23: 875-881.   DOI   ScienceOn
12 Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, Takahashi T, Nomura T. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006; 212: 8-27.   DOI   ScienceOn
13 Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-1164.
14 Sellin CI, Jégou JF, Renneson J, Druelle J, Wild TF, Marie JC, Horvat B. Interplay between virus-specific effector response and Foxp3 regulatory T cells in measles virus immunopathogenesis. PLoS One 2009; 4: e4948.   DOI   ScienceOn
15 Shevach EM. Cd4+ cd25+ suppressor t cells: More questions than answers. Nat Rev Immunol 2002; 2: 389-400.   DOI
16 Biller BJ, Guth A, Burton JH, Dow SW. Decreased ratio of cd8+ t cells to regulatory t cells associated with decreased survival in dogs with osteosarcoma. J Vet Intern Med 2010; 24: 1118-1123.   DOI   ScienceOn
17 Biller BJ, Elmslie RE, Burnett RC, Avery AC, Dow SW. Use of foxp3 expression to identify regulatory t cells in healthy dogs and dogs with cancer. Vet Immunol Immunopathol 2007; 116: 69-78.   DOI   ScienceOn